Screener
Lexicon Pharmaceuticals LXRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
| Assets | As of June 30, 2026 / (unaudited) | As of December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 1,643 | 2,384 |
| Inventory | 1,196 | 281 |
| Prepaid expenses and other current assets | 3,128 | 3,000 |
| Total current assets | 196,577 | 101,895 |
| Property and equipment, net | 1,651 | 1,863 |
| Goodwill | 44,543 | 44,543 |
| Operating lease right-of-use-assets | 6,921 | 7,318 |
| Restricted cash | — | 29,000 |
Item 1. Financial Statements
FAQ
- What is Lexicon Pharmaceuticals's total current assets?
- Lexicon Pharmaceuticals (LXRX) reported total current assets of $196.58M in Q2 2026.
- How has Lexicon Pharmaceuticals's total current assets changed year-over-year?
- Lexicon Pharmaceuticals's total current assets increased by 35.5% year-over-year, from $145.08M to $196.58M.
- What is the long-term trend for Lexicon Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's total current assets has grown at a -8.4% compound annual growth rate (CAGR), from $157.72M to $101.9M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Lexicon Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude